CW CURTISS WRIGHT CORP Insider Trading

CEO Lynn M Bamford sold 2,500 CW shares at $758.20 (2026-06-12), 1.3% below 52-week high; 10b5-1 plan execution.

Lynn M Bamford, Chair and CEO of Curtiss Wright, executed a sale of 2,500 shares for $1,895,500.00 on 2026-06-12 as part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-10. The sale occurred at $758.20, near the company's 52-week peak of $772.98 (1.3% below high), while the stock has gained 7.0% over the past 30 days and 12.2% over 90 days. Bamford's same-ticker selling history at CW shows mixed near-term results—three of five prior sales declined within 30 days (-2.1%, -1.5%, -0.6%), though all five trades yielded positive 90-day returns ranging from 8.4% to 44.4%. The underlying company posts strong fundamentals with $913.7M quarterly revenue, $128.2M net income, and 12.1% annual revenue growth, though valuation at a P/E of 55.14 reflects premium pricing. Since this sale is part of a scheduled 10b5-1 plan, it reflects administrative execution rather than discretionary timing decisions.

CEO Lynn M Bamford sold 2,500 shares of CW at $721.72; pre-arranged 10b5-1 plan execution, stock up 5.7% over 90 days.

Lynn M Bamford, Chair and CEO, sold 2,500 shares for $1,804,300.00 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-10, meaning the sale was scheduled and non-discretionary rather than a signal of confidence or concern. Bamford retains 48,134 shares post-transaction. Examining his same-ticker history at CW, his five prior sales have consistently been followed by positive 90-day returns: +8.4%, +16.4%, +22.2%, +13.2%, and +44.4%, suggesting his past sales at this company have preceded subsequent appreciation. The company shows solid fundamentals with $913,687,000.00 in latest quarterly revenue, $128,186,000.00 in net income, and 12.1% annual revenue growth; however, the P/E of 51.99 is elevated. The stock is trading 5.5% below its 52-week high of $760.72 and has gained 5.7% over the past 90 days, placing this transaction in a context of recent strength rather than distress.

CW CFO Farkas sells 1,265 shares at $689.69; holds 4,253 shares post-sale as stock near 52-week high

Farkas K Christopher, Executive VP and CFO, sold 1,265 shares on 2026-03-18 at $689.69, reducing his holdings by 22.9% and generating $872,457.85 in proceeds. The sale occurred near the 52-week high of $726.48 (current price $691.62 is 4.8% below that peak). His same-ticker history at CW shows a pattern of regular selling activity: five prior trades at this ticker, with only 0 of 2 measurable prior 90-day outcomes classified as well-timed (the most recent measurable sale on 2025-11-11 declined 1.5% in 30 days but rose 13.1% over 90 days, indicating poorly timed execution). Cross-ticker, his 7 prior sells averaged a 0.00% well-timed rate over 90 days. The company trades at a P/E of 46.86 with strong fundamentals: $869.2M in latest quarterly revenue, $124.8M net income, and 12.1% annual revenue growth, suggesting valuation may be elevated relative to near-term earnings power. The concentrated selling pattern at a historically high price point merits monitoring, though lack of measurable recent comparative outcomes limits definitive conclusions about timing intent.

CFO Farkas sells 918 CW shares at $677.46 (total $621.9K); stock up 27.4% in 90 days, P/E 46.81.

Farkas K Christopher, Executive VP and CFO, sold 918 shares of Curtiss Wright at $677.46, reducing his holdings from 6,436 to 5,518 shares. The sale occurred as the stock has appreciated significantly in the near term (up 27.4% over 90 days, with a current price of $690.94 just 4.9% below the 52-week high), positioning the transaction near a peak in recent momentum. At his prior five trades at this ticker, Farkas achieved a 0% well-timed rate on sells at the 90-day measurement mark, indicating his historical sales at CW have consistently been followed by further stock appreciation rather than declines. The company shows solid fundamentals with annual revenue growth of +12.1% and net income of $124.8M, though valuation metrics appear elevated at a P/E of 46.81. This sale pattern—disposing of shares during a strong uptrend without a track record of well-timed exits at this ticker—presents a data point for investor review.

CW COO Kevin Rayment sold 907 shares ($614.4K) at $677.38; holds 31.5K shares post-sale.

Kevin Rayment, Executive VP and COO, executed an open-market sale of 907 shares representing 2.8% of his pre-transaction holdings, reducing his stake from 32.4K to 31.5K shares. The transaction occurred at $677.38 on 2026-03-17, while the current price stands at $690.94 (near the 52-week high of $726.48). His prior trades at Curtiss Wright show a mixed pattern: a recent sell on 2026-02-04 gained 8.8% in the subsequent 30 days, but across his 3 measurable same-ticker sales, none demonstrated well-timed exit points at the 90-day mark. The sale occurs within a solid business context—annual revenue growth of 12.1% and a recent quarterly net income of $124.8M—though the elevated P/E of 46.81 reflects market expectations already baked into the stock price.

CEO Lynn M Bamford sold 3,225 shares of CW at $676.70, reducing holdings 6.0% to 50,634 shares ($2.2M transaction).

Lynn M Bamford, Chair and CEO of Curtiss Wright, sold 3,225 shares on 2026-03-17 at $676.70, reducing his position by 6.0% while retaining 50.6K shares post-transaction. The stock has traded at $690.94 currently, -4.9% from its 52-week high of $726.48, and has gained 27.4% over the past 90 days. His prior trades at CW show a pattern of sells that have not been well-timed at the 90-day mark: 0 of 4 prior sales at this ticker resulted in the stock declining afterward, instead rising an average 21.4% by day 90, suggesting the insider has consistently sold before subsequent gains. The company's fundamentals show strong growth with annual revenue up 12.1%, though the P/E of 46.81 reflects a premium valuation. This sale represents a continuation of his systematic selling pattern at this ticker and should be monitored against forward price action to confirm whether this transaction precedes a reversal of the recent 90-day uptrend.

CFO Farkas sells 3,105 shares (42.2% of holdings) at $694.51, reducing stake from 7.4K to 4.3K shares

CFO Christopher Farkas executed a substantial open-market sale of 3,105 shares on 2026-02-18 at $694.51, reducing his holdings by 42.2% in a single transaction. The sale price was at the 52-week high ($690.86), and the stock has appreciated 28.9% over 90 days and 4.1% over 30 days. His prior trades at Curtiss Wright show mixed timing outcomes: of 4 measurable prior trades at this ticker, none were well-timed at the 90-day mark. Cross-ticker, his 5 prior sales averaged 18.1% gains over 90 days, suggesting sells have historically been followed by stock appreciation rather than declines. The 42.2% reduction in position size represents a material reshaping of his stake in the company.

CFO Farkas K Christopher sold 2,665 shares of CW at $626.33 for $1,669,169.45; reduced holdings by 26.6% (from 10,023 to 7,358 shares)

Farkas K Christopher, Executive VP and CFO, executed a material reduction of his CW position, divesting 2,665 shares (26.6% of his pre-transaction holdings) at $626.33. The stock currently trades at $618.60, down 8.3% from its 52-week high of $674.79, suggesting the sale occurred near recent price strength. His prior trading history at CW shows mixed timing: of 5 prior trades at this ticker, only 1 of 4 measurable outcomes was well-timed at the 90-day mark, and his recent sell on 2025-11-11 saw prices decline 1.5% within 30 days. Cross-ticker, his sells have averaged a 90-day well-timed rate of 0.00%, indicating his exit decisions historically have not preceded stock declines. Curtiss Wright's fundamentals remain solid (P/E 49.06, +9.7% annual revenue growth, $124.8M net income), but the CFO's substantial single-transaction divestment warrants attention for its magnitude and pattern relative to his prior trading record.

CEO Bamford sells 9,327 shares of CW for $5.8M at $626.45; retains 46.2K shares post-sale

Bamford Lynn M, Chair and CEO, executed an open-market sale of 9,327 shares on 2026-02-04 for $5,842,899.15, reducing his holdings from 55,519 to 46,192 shares. The sale price of $626.45 was at the upper end of the company's 52-week range ($283.18–$674.79), only 8.3% below the 52-week high. At the same-ticker level, Bamford's prior 3 measurable sales at CW produced a 0% well-timed rate at the 90-day mark—none preceded subsequent declines—whereas his cross-ticker sell history shows a 25.00% well-timed rate overall. The company's fundamentals remain solid (P/E 49.06, +9.7% annual revenue growth, $124.8M net income on $869.2M quarterly revenue), and the stock is up 4.3% over the past 30 days and 6.9% over 90 days. Without a 10b5-1 plan or scheduled disposition flag disclosed, and given the executive retained substantial post-sale holdings, the transaction does not by itself signal distress; however, the pattern of recent sales at this ticker (three within three months) and the absence of well-timed prior exits at this company warrant investor attention to management's forward guidance.

CW COO Kevin Rayment sold 2,634 shares at $626.33 (2026-02-04); retains 29,896 shares post-sale.

Kevin Rayment, Executive VP and COO, sold 2,634 shares (2.6K shares) of Curtiss-Wright at $626.33, reducing his holdings by 8.1% to 29,896 shares. The stock currently trades at $618.60, slightly below the sale price, and sits 8.3% below its 52-week high of $674.79 while up 4.3% over the past 30 days and 6.9% over 90 days. Across his same-ticker history at CW (5 prior trades), Rayment's prior sell transactions have produced mixed outcomes: a 2025-02-05 sale resulted in -9.3% 30-day return and +4.7% 90-day return, while a 2024-06-03 sale saw -3.3% and +12.1% respectively—none of his three measurable CW sales were well-timed at the 90-day mark. The company shows solid fundamentals with $869.2M in quarterly revenue, $124.8M net income, and 9.7% annual revenue growth, though its P/E of 49.06 reflects a premium valuation. This sale represents routine portfolio activity from an executive with no demonstrated pattern of prescient selling timing at this ticker.